Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Oct 2026 for PharmaCorp Rx Inc., €27k.
Filing timeline
BuySaleKenneth Alva Brownell
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Kenneth Alva Brownell: trading record in brief
Kenneth Alva Brownell appears in our data through filings on PharmaCorp Rx Inc. shares, published by SEDI. The record holds 5 filings, for trades running from 6 June 2024 to 20 October 2026.
Every open-market trade on record is a purchase: 1 purchase worth €27k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 1 purchase and no sales.
Most recently, on 20 October 2026, the filings show an open-market purchase worth €27k in PharmaCorp Rx Inc. The median gap between a trade and its publication by SEDI is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.
Companies and markets linked to Kenneth Alva Brownell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
100,000 shares@ CA$0.41890.052% mcap21.3% of flowCommon SharesTSXSEDI:4793076
Canonical exit: 18 Jan 2027 (T+90)
Warrants Expiring 24 mos from Nov 12, 2025TSXSEDI:4766946
WarrantsTSXSEDI:4766945
119,000 shares@ CA$0.5037.3% of flowWarrants Expiring 24 mos from Nov 12, 2025TSXSEDI:4605667
238,000 shares@ CA$0.4262.7% of flowCommon SharesTSXSEDI:4605661
5 of 5 declarations
